Tag Archives: big pharma

U.S. taxpayers already paid for COVID-19 treatments — we cannot let Big Pharma make us pay again

U.S. taxpayers have already paid for the research and testing of the most promising treatments

There’s much we don’t yet know about COVID-19, the disease caused by the novel coronavirus. We don’t know how long the pandemic will last, when a vaccine will be developed, or how many lives antiviral medications can save. But there’s one thing we know for sure: U.S. taxpayers have already paid for the research and testing of the most promising treatments.

These treatments should be available to everyone who needs them at no cost. But the Trump administration’s drug policy is led by two former pharmaceutical executives, and that is having devastating consequences for potential access to treatments and vaccines for the COVID-19 pandemic.

If you’ve been watching Donald Trump’s daily press briefings, that might come as a surprise. During his 2016 campaign, Trump loved to talk tough on pharma and say he would fight for lower drug prices. But then he put Alex Azar, a big pharma CEO infamous for doubling the price of insulin, in charge of regulating health care. Several weeks ago, Azar refused to guarantee that a coronavirus vaccine will be affordable for all, citing the need to protect big pharma’s profits.

Read Full

BIG PHARMA PREPARES TO PROFIT FROM THE CORONAVIRUS

AS THE NEW CORONAVIRUS spreads illness, death, and catastrophe around the world, virtually no economic sector has been spared from harm. Yet amid the mayhem from the global pandemic, one industry is not only surviving, it is profiting handsomely.

“Pharmaceutical companies view Covid-19 as a once-in-a-lifetime business opportunity,” said Gerald Posner, author of “Pharma: Greed, Lies, and the Poisoning of America.” The world needs pharmaceutical products, of course. For the new coronavirus outbreak, in particular, we need treatments and vaccines and, in the U.S., tests. Dozens of companies are now vying to make them.

“They’re all in that race,” said Posner, who described the potential payoffs for winning the race as huge. The global crisis “will potentially be a blockbuster for the industry in terms of sales and profits,” he said, adding that “the worse the pandemic gets, the higher their eventual profit.”

Read Full

Scott, Campbell counties hop on board Big Pharma racketeering lawsuit train


Two East Tennessee counties are now on board to join a growing and fast-moving national effort to use federal racketeering laws to hold drug makers, distributors and dispensers accountable for creating and fostering the opioid epidemic in the United States, records show.

Government leaders in Campbell and Scott Counties have authorized the filing of lawsuits in U.S. District Court against the firms that make, distribute and dispense opiate prescription painkillers.

The law firm Jessee & Jessee filed the first such legal action in the federal Eastern District of Tennessee on behalf of Campbell County earlier this year. The law firms Lieff Cabraser Heimann & Bernstein and Taylor & Knight filed a similar action on behalf of Scott County late last week.

Full Read – https://www.knoxnews.com/story/news/crime/2018/03/06/scott-campbell-counties-opioid-epidemic-big-pharma-racketeering-lawsuits/399172002/

Drug companies want to dismiss Ohio’s lawsuit over opioid epidemic

CHILLICOTHE, Ohio – Companies that make prescription opioids want a Ross County Common Pleas judge to dismiss a lawsuit filed by Ohio Attorney General Mike DeWine that charged them with stoking Ohio’s opioid epidemic by fraudulently marketing their products.

Legal briefs filed by Purdue Pharma, which makes Oxycontin, say U.S. Food and Drug Administration requirements for its products preempt Ohio law, and DeWine’s lawsuit also failed to prove the company’s actions caused the harm he cites.

“The State does not identify a single physician who prescribed one of Purdue’s opioid medications to any patient when it was allegedly medically unnecessary, much less, a physician who did so because of Purdue’s allegedly misleading marketing or promotional materials,” the company’s legal filings say.

Read Full – http://www.cleveland.com/metro/index.ssf/2017/09/drug_companies_want_to_dismiss.html

FDA Wants To Stop Pharma From ‘Gaming’ Generic Drug System

The U.S. Food and Drug Administration moved on Wednesday to prevent pharmaceutical companies from “gaming” the system to block or delay entry of generic rivals.

FDA Commissioner Scott Gottlieb said in a blog post that the agency plans to hold a public meeting on July 18 to identify ways pharmaceutical companies are using FDA rules to place obstacles in the way of generic competition.

“We know that sometimes our regulatory rules might be ‘gamed’ in ways that may delay generic drug approvals beyond the time frame the law intended, in order to reduce competition,” he said in the blog post. “We are actively looking at ways our rules are being used and, in some cases, misused.”

The move comes as President Donald Trump and lawmakers in Congress search for ways to lower the cost of prescription drugs. Trump is preparing to put out an executive order on drug pricing, according to media reports, and last week U.S. Senator Ron Wyden introduced a bill to require companies to explain the reasons for significant price increases.

Full Read – http://www.nbcnews.com/health/health-news/fda-wants-stop-pharma-gaming-generic-drug-system-n775151